INmune Bio Inc. (INMB) financial statements (2020 and earlier)

Company profile

Business Address 1200 PROSPECT STREET
LA JOLLA, CA 92037
State of Incorp. NV
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,996186
Cash and cash equivalents6,996186
Receivables7737
Prepaid expense9816
Other undisclosed current assets594610
Total current assets:7,765849
Noncurrent Assets
Operating lease, right-of-use asset192
Intangible assets, net (including goodwill)16,51416,514
Intangible assets, net (excluding goodwill)16,51416,514
Total noncurrent assets:16,70616,514
TOTAL ASSETS:24,47017,363
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:402815
Other undisclosed accounts payable and accrued liabilities402815
Debt8 
Due to related parties2909
Total current liabilities:700824
Noncurrent Liabilities
Long-term debt and lease obligation160 
Operating lease, liability160
Total noncurrent liabilities:160 
Total liabilities:861824
Stockholders' equity
Stockholders' equity attributable to parent, including:23,61016,540
Common stock119
Additional paid in capital44,83425,446
Accumulated other comprehensive income (loss)(9)7
Accumulated deficit(21,276)(13,598)
Other undisclosed stockholders' equity attributable to parent504,676
Total stockholders' equity:23,61016,540
TOTAL LIABILITIES AND EQUITY:24,47017,363

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
Operating expenses(7,756)(12,440)
Operating loss:(7,756)(12,440)
Nonoperating income
(Other Nonoperating income)
78 
Net loss available to common stockholders, diluted:(7,678)(12,440)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
Net loss:(7,678)(12,440)
Comprehensive loss:(7,678)(12,440)
Other undisclosed comprehensive loss, net of tax, attributable to parent(15)(26)
Comprehensive loss, net of tax, attributable to parent:(7,693)(12,466)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: